BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3148927)

  • 1. [Dynamic thyroid function after the surgical treatment of patients with diffuse toxic goiter].
    Galkin RA; Popov AIu
    Probl Endokrinol (Mosk); 1988; 34(6):13-8. PubMed ID: 3148927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnosis of triiodothyronine thyrotoxicosis].
    Semenov VD
    Probl Endokrinol (Mosk); 1982; 28(6):32-5. PubMed ID: 6818538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of the thyroid gland function based on T3, T4 and TSH activity and histopathological changes in various types of goiter].
    Puchalski Z; Piotrowski Z; Chyczewski L; Orłowski K
    Pol Przegl Chir; 1980 Mar; 52(3):205-10. PubMed ID: 6893079
    [No Abstract]   [Full Text] [Related]  

  • 4. [Value of the thyroliberin test in the evaluation of the results of surgical treatment of patients with diffuse toxic goiter].
    Galkin RA; Popov AIu
    Probl Endokrinol (Mosk); 1988; 34(1):16-8. PubMed ID: 3129710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
    Chung YJ; Lee BW; Kim JY; Jung JH; Min YK; Lee MS; Lee MK; Kim KW; Chung JH
    Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [TRH test after subtotal thyroid resection for diffuse toxic goiter].
    Ibragin Md; Bazarova EN; Kandror VI
    Probl Endokrinol (Mosk); 1985; 31(6):12-6. PubMed ID: 3937156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.
    Sato A; Yamada T; Aizawa T; Ichikawa K; Komiya I; Takasu N; Takemura Y
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2173-7. PubMed ID: 7608274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormalities of hypothalamo-hypophyseal-thyroid axis in patients with Graves' ophthalmopathy.
    Chopra IJ; Chopra U; Orgiazzi J
    J Clin Endocrinol Metab; 1973 Dec; 37(6):955-67. PubMed ID: 4201831
    [No Abstract]   [Full Text] [Related]  

  • 9. Thyroid function in molar pregnancy.
    Nagataki S; Mizuno M; Sakamoto S; Irie M; Shizume K
    J Clin Endocrinol Metab; 1977 Feb; 44(2):254-63. PubMed ID: 402378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of serum T4 and T3 at the time of diagnosis in nosological types of thyrotoxicosis: a population-based study.
    Carlé A; Knudsen N; Pedersen IB; Perrild H; Ovesen L; Rasmussen LB; Laurberg P
    Eur J Endocrinol; 2013 Nov; 169(5):537-45. PubMed ID: 23935127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary-thyroid regulation in euthyroid patients with Graves' disease previously treated with antithyroid drugs.
    Buerklin EM; Schimmel M; Utiger RD
    J Clin Endocrinol Metab; 1976 Aug; 43(2):419-27. PubMed ID: 59733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute effects of corticosteroids on thyroid activity in Graves' disease.
    Williams DE; Chopra IJ; Orgiazzi J; Solomon DH
    J Clin Endocrinol Metab; 1975 Aug; 41(2):354-61. PubMed ID: 1174132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns off recovery of the hypothalamic-pituitary-thyroid axis in patients taken of chronic thyroid therapy.
    Krugman LG; Hershman JM; Chopra IJ; Levine GA; Pekary E; Geffner DL; Chua Teco GN
    J Clin Endocrinol Metab; 1975 Jul; 41(1):70-80. PubMed ID: 807596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
    Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
    J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term observation of thyroid function after surgical treatment of thyrotoxicosis.
    Blichert-Toft M; Jorgensen SJ; Hansen JB; Watt-Boolsen S; Christiansen C; Ibsen J
    Acta Chir Scand; 1977; 143(4):221-7. PubMed ID: 906756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothyroidism as a late sequela in patient with Graves' disease treated with antithyroid agents.
    Wood LC; Ingbar SH
    J Clin Invest; 1979 Nov; 64(5):1429-36. PubMed ID: 91625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary-thyroid feedback regulation in patients with Graves' disease during antithyroid drug therapy.
    Yamada T; Takasu N; Sato A; Aizawa T; Koizumi Y
    J Clin Endocrinol Metab; 1982 Jan; 54(1):83-8. PubMed ID: 6798061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low response of the thyroid gland to endogenous thyrotropin increased by thyrotropin-releasing hormone in patients with euthyroid Graves' disease.
    Kashiwai T; Tada H; Watanabe Y; Shimaoka Y; Yagoro A; Hidaka Y; Fujikado T; Amino N
    Thyroid; 1998 Oct; 8(10):881-5. PubMed ID: 9827654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro diagnosis of T3 thyrotoxicosis].
    Semenov VD
    Med Radiol (Mosk); 1983 Jun; 28(6):72-5. PubMed ID: 6688114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous pituitary-thyroid function after surgical treatment of nontoxic goitre. A controlled long-term study.
    Aagaard J; Blichert-Toft M; Axelsson CK; Christiansen C
    Acta Chir Scand; 1984; 150(2):123-7. PubMed ID: 6426224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.